跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,626 条关于
“GSK’227”
全部
4,626
临床试验
2,040
药物
1,676
机构
23
资讯
887
去年
GSK's GSK'227 Receives FDA Breakthrough Therapy Designation for Relapsed Osteosarcoma
去年
GSK's B7-H3-Targeted ADC, GSK'227, Receives FDA Breakthrough Therapy Designation for Osteosarcoma
去年
GSK's Cancer Portfolio Gains Momentum with Regulatory Successes for Dostarlimab and GSK'227
7年前
FDA Grants Breakthrough Therapy Designation for GSK's Osteosarcoma Treatment
去年
HS-20093 (GSK'227) Receives FDA and EMA Designations for Osteosarcoma and SCLC
10个月前
GSK Acquires Exclusive Rights to Syndivia's Preclinical ADC for Metastatic Castration-Resistant Prostate Cancer
9个月前
FDA Grants Orphan Drug Designation to GSK's B7-H3-Targeted ADC for Small-Cell Lung Cancer
2年前
GSK's GSK5764227 Receives FDA Breakthrough Therapy Designation for Extensive-Stage Small Cell Lung Cancer
3个月前
Osteosarcoma Pipeline 2026: HS-20093 Leads Phase III as Over 25 Companies Advance Novel Therapies
去年
Osteosarcoma Market Poised for Significant Growth Through 2034 as Novel Therapies Enter Pipeline
第 1 页,共 89 页
上一页
下一页